newsfilter
← Latest News
GlobeNewswire·

Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026

12-Month Phase 2 data in High-Risk NMIBC to be presented Friday, May 15, 2026Phase 3 overview to be presented at Trials-in-Progress session on Sunday, May 17, 2026The Phase 3 "RESCUE" registrational program remains on